The role of systemic corticosteroid therapy in erythema multiforme major and stevens-johnson syndrome a review of past and current opinions

Journal of Clinical and Aesthetic Dermatology

Volumn 2, Issue 3, 2009, Pages

  Michaels, Brent ^a   del Rosso, James Q ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; METHYLPREDNISOLONE; PREDNISONE; VACCINE;

ARTICLE; CORTICOSTEROID THERAPY; ERYTHEMA MULTIFORME; HERPES SIMPLEX VIRUS; HUMAN; KERATINOCYTE; MYCOPLASMOSIS; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; VIRUS INFECTION;

EID: 77954292809     PISSN: 19412789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rasmussen JE. Erythema multiforme in children. Response to treatment with systemic steroids. Br J Dermatol. 1976;95:181-186.
2. Ogundele O. Erythema multiforme. eMedicine (June 2006).
3. Forman R, Koren G, Shear NH. Erythema mutliforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf. 2002;25(13):965-972.
4. Lamoreux MR, Sternbach MR, Hsu WT. Erythema multiforme. Am Fam Physician. 2006;74:1883-1888.
5. French L, Prins C. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. 2nd ed. Philadelphia PA: Elsevier; 2008:287-300.
6. Scully C, Bagan J. Oral mucosal diseases: erythema multiforme. Br J Oral Maxillofac Surg. 2008;46:90-95.
7. Kardaun S, Jonkman M. Dexamethasone Pulse Therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol. 2007;87:144-148.
8. Chrousos GP. Adrenocorticosteroids and adrenocortical antagonists. In: Katzung BG, ed. Basic & Clinical Pharmacology. 9th ed. New York, NY: Lange Medical Books/McGraw-Hill; 2004:641-660.
9. Yeung AK, Goldman RD. Use of steroids for erythema multiforme in children. Can Fam Physician. 2005;51(11):1481-1483.
10. Tripathi A, Ditto AM, Grammer LC, et al. Corticosteroid therapy in an aadditional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases. Allergy and Asthma Proc. 2000;21:101-105.
11. Ginsburg CM. Stevens-Johnson syndrome in children. Pediatr Infect Dis J. 1982;1(3):155-158.
12. Nethercott JR, Choi BC. Erythema multiforme (Stevens-Johnson syndrome)-chart review of 123 hospitalized patients. Dermatologica. 1985;171(6):383-396.
13. Prendiville JS, Hebert AA, Greenwald MJ, Esterly NB. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Pediatr. 1989;115(6):881-887.
14. Ting HC, Adam BA. Erythema multiforme: response to corticosteroid. Dermatologica. 1984;169 (4):175-184.
15. Kakourou T, Klontza D, Soteropoulou F, Kattamis C. Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children. Eur J Pediatr. 1997;156:90-93.
16. Patterson R, Dykewicz MS, Gonzalzles A, et al. Erythema multiforme and Stevens-Johnson syndrome. Descriptive and therapeutic controversy. Chest. 1990;98:331-336.
17. Schneck J, Stat D, Fagot JP, et al. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol. 2008;58:33-40.
18. Patterson R, Miller M, Kaplan M, et al. Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis. Ann Allergy. 1994;73:27-34.
19. Martinez AE, Atherton DJ. High-dose systemic corticosteroids can arrest recurrences of severe mucocutaneous erythema multiforme. Pediatr Dermatol. 2000;17(2):87-90.
20. Wolverton SE. Systemic corticosteroids. In: Wolverton SE, ed. Comprehensive Dermatologic Drug Therapy. 2nd ed. Philadelphia, PA: Saunders Elsevier;2007:127-161.